Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFSI
4076
Dimensional International Sustainability Core 1 ETF
DFSI
$1.19B
| $5.63M | ﹤0.01% |
131,333
+58,413
| +80% | +$2.43M |
|
4077
PUT
Upwork
UPWK
$1.19B
| $5.63M | ﹤0.01% |
283,900
+165,400
| +140% | +$3.03M |
|
4078
Sensient Technologies
SXT
$5.53B
| $5.63M | ﹤0.01% |
59,887
-440,074
| -88% | -$41.5M |
|
4079
PUT
Quest Diagnostics
DGX
$26.3B
| $5.62M | ﹤0.01% |
32,400
-3,900
| -11% | -$710K |
|
4080
PUT
Vital Farms
VITL
$525M
| $5.62M | ﹤0.01% |
176,000
+26,100
| +17% | +$919K |
|
4081
Walker & Dunlop
WD
$1.53B
| $5.62M | ﹤0.01% |
93,453
+42,745
| +84% | +$3.03M |
|
4082
PUT
Performance Food Group
PFGC
$18B
| $5.62M | ﹤0.01% |
62,500
+19,100
| +44% | +$1.84M |
|
|
ORC
4083
Orchid Island Capital
ORC
$1.31B
| $5.62M | ﹤0.01% |
780,517
+235,011
| +43% | +$1.71M |
|
4084
LCI Industries
LCII
$2.65B
| $5.62M | ﹤0.01% |
46,295
-345,051
| -88% | -$36.7M |
|
4085
FlexShares STOXX Global ESG Select Index Fund
ESGG
$115M
| $5.61M | ﹤0.01% |
27,323
+16,634
| +156% | +$3.35M |
|
4086
Crane NXT
CXT
$3.07B
| $5.6M | ﹤0.01% |
119,068
+49,691
| +72% | +$2.94M |
|
4087
CALL
TKO Group
TKO
$13.6B
| $5.6M | ﹤0.01% |
26,800
+9,500
| +55% | +$1.85M |
|
|
MASI
4088
DELISTED
Masimo
MASI
| $5.6M | ﹤0.01% |
43,052
-44,698
| -51% | -$6.4M |
|
4089
WisdomTree India Earnings Fund ETF
EPI
$2.06B
| $5.58M | ﹤0.01% |
120,616
-298,816
| -71% | -$13.7M |
|
4090
CALL
Summit Therapeutics
SMMT
$11.1B
| $5.58M | ﹤0.01% |
318,800
-278,900
| -47% | -$5.25M |
|
4091
CALL
Helmerich & Payne
HP
$3.71B
| $5.58M | ﹤0.01% |
194,400
-7,900
| -4% | -$210K |
|
|
RC
4092
Ready Capital
RC
$308M
| $5.57M | ﹤0.01% |
2,557,145
+1,843,244
| +258% | +$5.16M |
|
4093
CALL
Infosys
INFY
$50.7B
| $5.57M | ﹤0.01% |
312,700
+47,700
| +18% | +$825K |
|
4094
CALL
Pembina Pipeline
PBA
$27.6B
| $5.57M | ﹤0.01% |
146,300
+81,000
| +124% | +$3.12M |
|
4095
Innospec
IOSP
$2.28B
| $5.56M | ﹤0.01% |
72,694
-10,695
| -13% | -$808K |
|
4096
PUT
PennyMac Financial
PFSI
$4.02B
| $5.56M | ﹤0.01% |
42,200
-12,000
| -22% | -$1.53M |
|
|
ROBN
4097
CALL
T-Rex 2X Long HOOD Daily Target ETF
ROBN
$94.6M
| $5.56M | ﹤0.01% |
102,700
-69,700
| -40% | -$5.75M |
|
4098
PUT
MoonLake Immunotherapeutics
MLTX
$1.55B
| $5.56M | ﹤0.01% |
421,600
+226,000
| +116% | +$2.67M |
|
4099
MicroSectors FANG & Innovation 3x Leveraged ETN
BULZ
$311M
| $5.54M | ﹤0.01% |
213,400
-33,500
| -14% | -$915K |
|
4100
BrightSpring Health Services
BTSG
$12.4B
| $5.54M | ﹤0.01% |
147,898
-106,049
| -42% | -$3.56M |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.